Sutimlimab is an intravenous monoclonal antibody targeting complement component 1s (C1s) for the treatment of cold agglutinin disease.
Sutimlimab for Cold Agglutinin Disease
read more
Publications
Researched and Curated by Clinical and Scientific Experts.Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.
Not all reports are available for public preview. For more information, please contact us.
Mavacamten for Hypertropic Cardiomyopathy
Mavacamten is an investigational oral myosin inhibitor that targets the underlying molecular mechanisms of hypertrophic cardiomyopathy (HCM). It is proposed for the treatment of patients with obstructive HCM.
Breast Cancer Index (BioTheranostics Inc.) for Lymph Node–Negative Patients
This report evaluates the analytical validity, clinical validity, and clinical utility of the Breast Cancer Index test (BioTheranostics Inc.) for lymph node–negative patients.
Breast Cancer Index (BioTheranostics Inc.) for Lymph Node–Positive (1-3) Patients
This report evaluates the analytical validity, clinical validity, and clinical utility of the Breast Cancer Index test (BioTheranostics Inc.) for lymph node–positive (1-3) patients.
Vosoritide for Achondroplasia
Vosoritide is a longer-acting C-type natriuretic peptide (CNP) analog that modulates activity of the fibroblast growth factor receptor 3 (FGFR3) by inhibiting a signaling pathway that mediates its effects, thereby stimulating endochondrial growth, resulting in enhanced growth velocity. It is proposed for the treatment of achondroplasia.
Idecabtagene Vicleucel for Multiple Myeloma
Idecabtagene vicleucel is an investigational chimeric antigen receptor (CAR) T-cell therapy targeting B-cell maturation antigen (BCMA). It is proposed for the treatment of adults with relapsed/refractory multiple myeloma who have received at least 3 prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.
Autologous Fat Grafting for Breast Reconstruction After Breast Cancer Surgery
Focus of the Report: Autologous fat grafting (AFG) is used as an adjunct or primary breast reconstruction procedure in women following breast cancer surgery.
Technology Description: AFG is a minimally invasive procedure that utilizes a patient’s own body fat to fill and correct volume …
Radiolabeled Omburtamab for Metastatic Neuroblastoma
A radiolabeled monoclonal antibody targeting tumor antigen B7-H3 in development for intraventricular radioimmunotherapy for treatment of neuroblastoma central nervous system/leptomeningeal metastases.
WiSE Cardiac Resynchronization Therapy System
The WiSE CRT system is a wireless left ventricular pacing system that works with an implanted right ventricular pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated.
Remestemcel-L for Acute Graft-Versus-Host Disease
Remestemcel-L is an investigational allogeneic liquid cell suspension of ex-vivo cultured adult human mesenchymal stem cells derived from healthy donor bone marrow proposed for the treatment of pediatric patients with acute graft-versus-host-disease (aGVHD) refractory to standard first-line steroid therapy.